RxDoctor Payments DataLook up a doctor →

Second Generation Travoprost Intracameral Implant (TREX): payments to doctors

Payments that named Second Generation Travoprost Intracameral Implant (TREX) as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$58K
Providers
1
Transactions
2
Average per transaction
$29,000

The per-transaction average — $29,000 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1 providers the average total is $58,000, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Glaukos Corporation$58,000100.0%
← All drugs & devices